About OncoStem
OncoStem is a company based in Bengaluru (India) founded in 2011 by Manjiri Bakre.. OncoStem has raised $9 million across 2 funding rounds from investors including Peak XV Partners and Artiman. The company has 17 employees as of April 08, 2024. OncoStem operates in a competitive market with competitors including Denali Therapeutics, Poseida Therapeutics, Castle Biosciences, Juno Therapeutics and Unity Biotechnology, among others.
- Headquarter Bengaluru, India
- Employees 17 as on 08 Apr, 2024
- Founders Manjiri Bakre
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Oncostem Diagnostics Private Limited
- Date of Incorporation 15 Mar, 2011
- Jurisdiction Bangaluru, Karnataka, India
-
Annual Revenue
$709.5 K (USD)-43.66as on Mar 31, 2023
-
Net Profit
$-244.33 K (USD)-2016.27as on Mar 31, 2023
-
EBITDA
$-233.29 K (USD)-3613.18as on Mar 31, 2023
-
Total Equity Funding
$9 M (USD)
in 2 rounds
-
Latest Funding Round
$6 M (USD), Series A
Sep 06, 2017
-
Investors
Peak XV Partners
& 1 more
-
Employee Count
17
as on Apr 08, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of OncoStem
OncoStem has successfully raised a total of $9M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $6 million completed in September 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $6.0M
-
First Round
First Round
(01 Jun 2011)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2017 | Amount | Series A - OncoStem | Valuation | Peak XV Partners | |
| Jun, 2011 | Amount | Seed - OncoStem | Valuation | Artiman |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in OncoStem
OncoStem has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Peak XV Partners and Artiman. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm investing in technology and healthcare sectors.
|
Founded Year | Domain | Location | |
|
Venture capital firm investing in startups and providing support programs.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by OncoStem
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - OncoStem
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Oncostem Comparisons
Competitors of OncoStem
OncoStem operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Denali Therapeutics, Poseida Therapeutics, Castle Biosciences, Juno Therapeutics and Unity Biotechnology, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
|
|
| domain | founded_year | HQ Location |
Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies
|
|
| domain | founded_year | HQ Location |
Precision diagnostic and prognostic tests are developed by Castle Biosciences.
|
|
| domain | founded_year | HQ Location |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for aging diseases are developed by targeting senescent cells.
|
|
| domain | founded_year | HQ Location |
Diagnostic services are provided through laboratories and radiology units.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Oncostem
Frequently Asked Questions about OncoStem
When was OncoStem founded?
OncoStem was founded in 2011.
Where is OncoStem located?
OncoStem is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Who is the current CEO of OncoStem?
Manjiri Bakre is the current CEO of OncoStem. They have also founded this company.
Is OncoStem a funded company?
OncoStem is a funded company, having raised a total of $9M across 2 funding rounds to date. The company's 1st funding round was a Seed of $3M, raised on Jun 01, 2011.
How many employees does OncoStem have?
As of Apr 08, 2024, the latest employee count at OncoStem is 17.
What is the annual revenue of OncoStem?
Annual revenue of OncoStem is $709.5K as on Mar 31, 2023.
What does OncoStem do?
OncoStem was founded in 2011 in Bengaluru, India, and operates in the oncology diagnostics sector. Prognostic tests for cancer are developed, with the flagship product CanAssist-Breast employing an AI-based statistical model to assess breast cancer recurrence risk. Additional tumor details are provided to support customized treatment decisions. The company focuses on enhancing clinical outcomes through precise risk stratification.
Who are the top competitors of OncoStem?
OncoStem's top competitors include Juno Therapeutics, Poseida Therapeutics and Denali Therapeutics.
Who are OncoStem's investors?
OncoStem has 2 investors. Key investors include Peak XV Partners, and Artiman.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.